相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells
Emily M. E. Barnes et al.
BRITISH JOURNAL OF CANCER (2020)
Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis
Barbora Pavlatovska et al.
FRONTIERS IN ONCOLOGY (2020)
New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy
Gang Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
BCL-2 family isoforms in apoptosis and cancer
Chloe F. A. Warren et al.
CELL DEATH & DISEASE (2019)
A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair
Zhiwang Song et al.
CELL DEATH & DISEASE (2019)
Quantitative Assessment of Anti-Cancer Drug Efficacy From Coregistered Mass Spectrometry and Fluorescence Microscopy Images of Multicellular Tumor Spheroids
Jan Michalek et al.
MICROSCOPY AND MICROANALYSIS (2019)
Drug Penetration Analysis in 3D Cell Cultures Using Fiducial-Based Semiautomatic Coregistration of MALDI MSI and Immunofluorescence Images
Marketa Machalkova et al.
ANALYTICAL CHEMISTRY (2019)
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Ana S. Nunes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
2D and 3D cell cultures - a comparison of different types of cancer cell cultures
Marta Kapalczynska et al.
ARCHIVES OF MEDICAL SCIENCE (2018)
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis
Keertan Dheda et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response
Aline G. Souza et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Analysis of a gene panel for targeted sequencing of colorectal cancer samples
Klaus Højgaard Jensen et al.
Oncotarget (2018)
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
Chiara Molinari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Combine and conquer: challenges for targeted therapy combinations in early phase trials
Juanita S. Lopez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate
Jarmila Navratilova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
ABT-737 potentiates cisplatin- induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway
Fengtian Zhang et al.
ONCOLOGY REPORTS (2017)
Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells
Malgorzata Opydo-Chanek et al.
TOXICOLOGY IN VITRO (2017)
Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Safieh Ebrahimi et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Perifosine and ABT-737 synergistically inhibit lung cancer cells in vitro and in vivo
Jie Shen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Role of Akt signaling in resistance to DNA-targeted therapy
Abolfazl Avan et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
Portrait of the PI3K/AKT pathway in colorectal cancer
Stine Aske Danielsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Limited Mitochondrial Permeabilization Causes DNA Damage and Genomic Instability in the Absence of Cell Death
Gabriel Ichim et al.
MOLECULAR CELL (2015)
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
Stefany Moreno-Gamez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo
Jianli Zhang et al.
TUMOR BIOLOGY (2015)
Spatial Heterogeneity in Drug Concentrations Can Facilitate the Emergence of Resistance to Cancer Therapy
Feng Fu et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
Rasheena Edmondson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer
K. Malinowsky et al.
BRITISH JOURNAL OF CANCER (2014)
Synergistic Enhancement of Cancer Therapy Using a Combination of Ceramide and Docetaxel
Li-Xia Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Role of AKT signaling in DNA repair and clinical response to cancer therapy
Qun Liu et al.
NEURO-ONCOLOGY (2014)
Acidic pH of Tumor Microenvironment Enhances Cytotoxicity of the Disulfiram/Cu2+ Complex to Breast and Colon Cancer Cells
Jarmila Navratilova et al.
CHEMOTHERAPY (2013)
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
S. L. Locatelli et al.
LEUKEMIA (2013)
Perifosine, an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity
Paul G. Richardson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Acidosis Promotes Bcl-2 Family-mediated Evasion of Apoptosis INVOLVEMENT OF ACID-SENSING G PROTEIN-COUPLED RECEPTOR GPR65 SIGNALING TO MEK/ERK
Christopher Ryder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
BH3-only proteins: Orchestrators of apoptosis
Aisha Shamas-Din et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
The BH3 Mimetic ABT-737 Induces Cancer Cell Senescence
Jin H. Song et al.
CANCER RESEARCH (2011)
Hypoxic human cancer cells are sensitized to BH-3 mimetic-induced apoptosis via downregulation of the Bcl-2 protein Mcl-1
Luke R. E. Harrison et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The Novel Bcl-2 Inhibitor ABT-737 Is More Effective in Hypoxia and Is Able to Reverse Hypoxia-Induced Drug Resistance in Neuroblastoma Cells
Tetyana Klymenko et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Jonathan W. Wojtkowiak et al.
MOLECULAR PHARMACEUTICS (2011)
The Bcl-xL Inhibitor, ABT-737, Efficiently Induces Apoptosis and Suppresses Growth of Hepatoma Cells in Combination with Sorafenib
Hayato Hikita et al.
HEPATOLOGY (2010)
Acidic preconditioning protects endothelial cells against apoptosis through p38-and Akt-dependent Bcl-xL overexpression
Jan-Paul Flacke et al.
APOPTOSIS (2009)
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress
Adrienne N. Howard et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
K. D. Mason et al.
LEUKEMIA (2009)
Perifosine: Update on a Novel Akt Inhibitor
Joell J. Gills et al.
CURRENT ONCOLOGY REPORTS (2009)
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K. E. Tagscherer et al.
ONCOGENE (2008)
The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers
Julia Ling-Yu Chen et al.
PLOS GENETICS (2008)
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737
Stephen K. Tahir et al.
CANCER RESEARCH (2007)
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
Marina Konopleva et al.
CANCER CELL (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Treatment resistance of solid tumors - Role of hypoxia and anemia
P Vaupel et al.
MEDICAL ONCOLOGY (2001)
Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139
EP Rogakou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)